Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K Bernstein Fund Inc
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K Bernstein Fund Inc
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K BERNSTEIN SANFORD C FUND
-
Form 497K Bernstein Fund Inc
-
This is the best lodging stock for 2025, Bernstein says
-
Atlassian Corporation (TEAM) PT Raised to $325 at Bernstein as 'Beats are Rising'
-
Bernstein Reiterates Outperform Rating on Visa (V), Citing 'Increasingly Attractive 2025 Setup'
-
Thermo Fisher Scientific (TMO) PT Raised to $690 at Bernstein SocGen Group
-
Bernstein Calls Hyatt Hotels (H) 'Best Lodging Idea for 2025'
-
Regeneron Pharma (REGN) PT Lowered to $1,000 as Bernstein 'Expects EPS Miss Given Today's Dupixent Results'
-
Bernstein: 'Boeing (BA) Entering 2025 with Strong optimism - The Key will be Execution'; PT Raised
-
Bernstein: 'Oshkosh (OSK) Started the Year on a Strong Note'; PT Raised to $121 at Bernstein
-
Caterpillar (CAT) PT Lowered to $360 at Bernstein; 'Is this what the bottom looks like?'
-
General Dynamics Corp. (GD) PT Lowered to $290 at Bernstein, Citing 'Two Big Challenges after 2024'
-
Factbox-Wall Street braces for potential fallout as Trump tariffs on Canada, Mexico draw near
-
Intel rises on revenue beat as CEO hunt dominates investor focus
-
3 reasons why these two payments stocks may outperform in 2025: Bernstein
-
Bernstein SocGen Group on Intel (INTC): 'Q424 Recap - (Un)comfortably numb'
-
Adecco Group AG (ADEN:SW) (AHEXY) PT Lowered to CHF25.30 at Bernstein SocGen Group
-
Bernstein SocGen Group Upgrades Air Products & Chemicals Inc. (APD) to Outperform
-
Bernstein explains why PayPal is a catalyst-rich battleground stock in 2025
-
Form 3 Maze Therapeutics, Inc. For: Jan 30 Filed by: Bernstein Harold
-
The Hartford Announces Outstanding Results For The Fourth Quarter and Full Year 2024
-
This AI stock is down 30% on DeepSeek's R1 launch. Buy the dip says analyst
-
ASML to stop publishing most-closely watched metric - bookings
-
CGI Group Inc (GIB/A:CN) (GIB) PT Raised to Cdn$144 at Bernstein
-
Microsoft (MSFT) PT Lowered to $511 at Bernstein as 'Core Azure Disappoints'
-
Bernstein: 'PayPal (PYPL) is a Catalyst-Rich Battleground Stock in 2025'; PT Raised to $94
-
Lockheed Martin (LMT) PT Lowered to $541 at Bernstein Amid Cost Overruns
-
RTX Corp. (RTX) PT Raised to $136 at Bernstein Following Q4 Beat
-
Alphabet (GOOGL) PT Raised to $210 at Bernstein; 'We're Mostly Constructive on the 4Q Setup'
-
ServiceNow (NOW) PT Raised to $1,021 at Bernstein as AI Accelerates
-
Amazon.com (AMZN) PT Raised to $280 at Bernstein; 'We Expect AWS to Continue Accelerating in Q4'
-
Meta Platforms Inc. (META) PT Raised to $800 at Bernstein SocGen Group
-
Bernstein SocGen Group Upgrades Lam Research (LRCX) to Outperform
-
This European Medtech Stock is Bernstein's top pick for 2025
-
ASML CEO makes case that DeepSeek is positive for chip demand
-
Coinbase adds Trump campaign manager, ex-senator to advisory council
-
Semicap stocks rise following strong ASML earnings
-
Bloom Burton & Co. Announces the 2025 Bloom Burton Award
-
Bernstein on McCormick & Company (MKC): 'Time to Sprinkle This Over Everything'
-
Bernstein Reiterates Outperform Rating on Starbucks (SBUX) Following 'Better-than-Feared 1Q Results'
